Angle-closure glaucoma (ACG) is a severe form of glaucoma affecting up to 16 million people worldwide. In ACG, physical blockage of the ocular drainage tissue by the peripheral iris impedes the drainage of aqueous humor resulting in elevated intraocular pressure (IOP) and subsequent optic nerve damage. Despite the high prevalence of ACG, the precise mechanism(s) underlying pathogenesis are only partially understood. We have previously demonstrated that a mutation in the gene encoding the serine protease PRSS56 causes an ACG phenotype in mice. Notably, Prss56 mutant mice exhibit a reduced ocular axial length and a lens occupying a larger ocular volume compared to WT mice, recapitulating characteristic features of human AGC. Our findings utilizing mouse genetic models demonstrate that loss of PRSS56 function results in altered configuration of ocular angle structures characterized by a posterior shift in the positioning of the ocular drainage tissue relative to the ciliary body and iris during development, leading to a physical blockage of drainage structure (angle closure) and high IOP. Utilizing a previously employed genetic strategy of rescuing mutant Prss56 mediated reduction in ocular size by inactivation of EGR1 (Egr1;Prss56 double mutants) we determined the influence of ocular size on developmental positioning of the ocular angle tissues. Our findings suggest that abnormal positioning of the drainage structure as a result of loss of PRSS56 function is uncoupled from its effect on ocular axial length reduction. Furthermore, we demonstrate that the IOP elevation observed in Prss56 mutant mice is genetic context-dependent and identify a dominant modifier locus on Chromosome 2 of the C3H/HeJ genome conferring susceptibility to high IOP. Overall, our findings reveal a novel role for PRSS56 in the proper configuration of the iridocorneal angle and provide new insight into the developmental pathways implicated in glaucoma pathogenesis.
Introduction
Glaucoma is a leading cause of blindness and refers to a heterogeneous group of diseases characterized by progressive loss of retinal ganglion cells (RGCs) and corresponding visual field defects. One of the major risk factors for developing glaucoma is elevated intraocular pressure (IOP) 1 . Regulation of IOP mainly relies on the balance between aqueous humor (AqH) production in the ciliary body and its exit through ocular drainage structures located at the iridocorneal angle that forms at the junction between the iris and the cornea 2, 3 . The key ocular drainage structures consist of the trabecular meshwork (TM) and the Schlemm's canal. AqH enters the TM and subsequently drains into the Schlemm's canal before entering the collector channels, which culminate in the episcleral veins 4, 5 .
Consistent with a critical role for the ocular drainage structures in AqH outflow regulation, structural or functional alterations of these structures impair AqH outflow, leading to elevated IOP 6, 7 . Depending on the configuration of the iridocorneal angle, glaucoma is broadly divided into primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) 7, 8 . In PACG, altered positioning of the peripheral iris causes blockade and closure of the iridocorneal angle preventing access of AqH to the drainage tissues.
Pupillary block and plateau iris configuration (PIC) are the two major conditions implicated in the etiology of PACG 7, 9, 10 . Anatomical features such as reduced ocular size, relatively larger lens, and a shallow anterior chamber predispose individuals to pupillary block, thereby restricting the flow of AqH from the posterior to anterior chamber 11 . The accumulation of the AqH in the posterior chamber causes the iris to bulge anteriorly, leading to its apposition against the ocular drainage tissue. Plateau iris configuration is characterized by the forward displacement of the peripheral iris by an anteriorly localized ciliary body/pars plana that can lead to angle closure 12, 13 .
ACG is a complex disease resulting from an intricate interplay between genetic and environmental factors. Although specific anatomical features are well established to predispose to ACG, they are generally not sufficient to induce angle closure/high IOP and other contributing factors remain largely unknown 11 . We have previously demonstrated that mutations in the gene coding for the secreted serine protease PRSS56 result in severe reduction in ocular axial length (nanophthalmos) in humans and many of these individuals go on to develop ACG [14] [15] [16] (Fig. 3C ). These findings indicate that PRSS56 is required prior to P18, for proper positioning of angle structures.
Mutant Prss56 induced high IOP is dependent on genetic context
The role of genetic context in modulating the severity and penetrance of disease-causing mutations is well established. We found that both the mean IOP and the proportion of Prss56 mutant mice developing high IOP (>18mmHg, 3 SD above normal IOP) are significantly greater when maintained on a C3H/HeJ (C3H) background compared to a DBA/2J (D2) background at 3 and 6 months of age ( Fig. 4A-B) . These findings indicate that the C3H background confers susceptibility to IOP elevation caused by a loss of Prss56 function mutation (Prss56 glcr4 ).
Notably, the C3H background was also more permissive to the ocular size reduction resulting from a Prss56 mutation, as shown by a significantly shorter ocular axial length in Prss56 mutant mice maintained on C3H background compared to those maintained on a D2 background (Fig. 4C) . The more greatly reduced ocular size may or may not exacerbate the IOP phenotype but further experiments are needed to assess this.
As a first step to identify modifier loci predisposing Prss56 mutant mice to develop high IOP, we crossed mice that were congenic for the Prss56 mutation on a C3H genetic background to mice that were congenic for the Prss56 mutation on a D2 genetic background, which are less susceptible to developing high IOP. The C3HD2F1 progeny was backcrossed to D2.Prss56 mutant mice and the IOP was measured in the resulting N2 progeny between 3 and 8 months of age. Quantitative Trait Linkage (QTL) analysis was performed to identify genetic regions conferring susceptibility to high IOP caused by the Prss56 mutation. QTL analysis using IOP values as a continuous trait identified a region on the C3H Chr 2 that is strongly associated with high IOP (Fig. 5A) . Furthermore, our analysis shows that this C3H Chr2 locus (60-130 Mb) act in a dominant manner to confer susceptibility to high IOP in response to loss of PRSS56 function (Fig. 5B, Fig.   S1 ).
Discussion
Here, we demonstrate that in addition to its role in ocular size determination, PRSS56 is required for proper positioning of angle structures during ocular development. We show that loss of PRSS56 function during postnatal development leads to an angle-closure phenotype and high IOP. Importantly, our findings suggest that the angle closure phenotype resulting from loss of PRSS56 function is not dependent on ocular axial length reduction. In addition, we demonstrate that the high IOP phenotype resulting from a Prss56 mutation is genetic context -dependent and we have identified a dominant modifier locus on Chr2 from the C3H genetic background conferring increased susceptibility to IOP elevation.
We have previously reported that a mutation in PRSS56 caused nanophthamos, a condition characterized by severe reduction in ocular axial length, in humans 14 .
Nanophthalmic individuals are anatomically predisposed to develop a narrow angle and exhibit a high prevalence of angle closure glaucoma 14, 20 . Here, we used genetic mouse models to demonstrate that in addition to causing ocular size reduction, loss of PRSS56 function results in altered positioning of the ocular drainage structures and high IOP. Mouse lines used in this study: 
IOP Measurement
IOP was measured using the microneedle method as described previously 34 . In brief, the mice were anesthetized by intraperitoneal injection of a mixture of ketamine (99 mg/kg; Ketalar, Parke-Davis, Paramus, NJ) and xylazine (9 mg/kg; Rompun, Phoenix Pharmaceutical, St. Joseph, MO). IOP was measured in both male and female mice. Prior to measuring IOP on experimental mice, the device was calibrated. We measured IOP in a small cohort of C57BL/6J mice along with the experimental mice as a methodological control. To show the difference in the number of mice with elevated IOP in each group we displayed the data using k-means clustering (k=3).
Ocular biometry
We performed mouse ocular biometry using the Envisu R4300 spectral domain optical coherence tomography (SD-OCT, Leica/Bioptigen Inc., Research Triangle Park, NC, USA) as described previously 35 . Mice were anesthetized with ketamine/xylazine (100 mg/kg and 5mg/kg) and their eyes dilated before performing ocular biometry measurements. The distance from the corneal surface to the retinal pigment epithelium/choroid interface provided axial length measurements. VCD was calculated by measuring the distance between the innermost layer of the retina and the lens. To minimize any confounding effect of body weight on ocular size, we only selected littermates with comparable body weights in each of the experimental groups.
Ocular Histology
After euthanizing the mice, their eyes were enucleated and immersed in cold fixative (1% PFA, 2% glutaraldehyde, and 0.1 M cacodylate buffer cacodylate buffer) for a minimum of 48 hours. The fixed eyes were then transferred to 0.1 M cacodylate buffer solution and stored in a refrigerator till further use.
The eyes were then embedded in glycol methacrylate, and then sectioned using a microtome. Serial sagittal sections (2μm) were made by passing through the optic nerve and the sections were stained with hematoxylin and eosin (H&E). Hematoxylin and eosin stained ocular sections were assessed to determine the configuration of ocular angle structures. We evaluated at least 15-30 similarly spaced sections from 2 ocular regions (mid-peripheral and central).
Gene Mapping and QTL studies
The Prss56 mutant allele (Prss56 glcr4 ) was introduce into the two genetically divergent C3H/HeJ (C3H) and DBA/2J (D2) inbred mouse strains and backcrossed for at least 10 generations. D2 mice spontaneously develop high IOP and glaucoma due to a mutation in Gpnmb. Hence, we have used the DBA/2J-Gpnmb + /SjJ sub-strain of D2 mice that has been corrected for the mutation in Gpnmb. Similarly, we utilized a C3H substrain corrected for the inherent PDE6b mutation causing retinal degeneration (C3A.BLiA-Pde6b + /J).
To identify the genetic locus predisposing Prss56 mutant mice to develop high IOP on the C3H background, Prss56 glcr4 .C3H mice were bred to D2 mice, which are typically less permissive to developing high IOP and the resulting Prss56 glcr4 CH3.D2 F1 progeny was backcrossed to the D2 background. A total of 175 N2 progeny mice were aged up to 9 months and their IOP was measured at multiple time points between the ages of 3 to 9 months. Genotyping was performed using over 116 genome-wide single nucleotide polymorphic markers that are distinct between the C3H and D2 genomes and spaced at approximately 20 MB intervals (SNPs, KBioscience, UK). Genotyping quality assessment was done by evaluating the recombination fraction plot and map plot 36 . Pseudomarkers were generated at 2 cM spacing for each chromosome. The log transformed IOP values showed a normal distribution were therefore used for further analysis (Fig S1) . We performed a genome-wide one-QTL scan using 256 imputations to identify the chromosomal loci regulating IOP (NCBI Build 37).
Thousand permutations were performed to calculate the three thresholds for QTL detection at 1%, 5%, and 10%. A QTL with LOD score above the 1% threshold was identified as a strong QTL, while anything at or above 10% were suggestive QTL. Plot showing QTL confidence interval on chromosome 2.
